| __timestamp | Amneal Pharmaceuticals, Inc. | Catalent, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 334800000 |
| Thursday, January 1, 2015 | 109679000 | 337300000 |
| Friday, January 1, 2016 | 118757000 | 358100000 |
| Sunday, January 1, 2017 | 109046000 | 402600000 |
| Monday, January 1, 2018 | 230435000 | 462600000 |
| Tuesday, January 1, 2019 | 289598000 | 512000000 |
| Wednesday, January 1, 2020 | 326727000 | 577900000 |
| Friday, January 1, 2021 | 365504000 | 687000000 |
| Saturday, January 1, 2022 | 399700000 | 844000000 |
| Sunday, January 1, 2023 | 429675000 | 831000000 |
| Monday, January 1, 2024 | 935000000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Catalent, Inc. and Amneal Pharmaceuticals, Inc. have been on this journey since 2014. Over the years, Catalent has consistently outpaced Amneal in SG&A spending, with a peak of approximately $935 million in 2024, reflecting a 180% increase from 2014. In contrast, Amneal's SG&A expenses grew by about 400% over the same period, reaching around $430 million in 2023. This disparity highlights Catalent's aggressive expansion strategy, while Amneal's more conservative approach suggests a focus on cost efficiency. However, the absence of Amneal's 2024 data leaves room for speculation. As the industry evolves, these trends offer valuable insights into each company's strategic priorities and financial health.
Comparing SG&A Expenses: AbbVie Inc. vs Catalent, Inc. Trends and Insights
GSK plc or Amneal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for argenx SE and Amneal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Genmab A/S vs Catalent, Inc.
Selling, General, and Administrative Costs: Catalent, Inc. vs Walgreens Boots Alliance, Inc.
Breaking Down SG&A Expenses: Catalent, Inc. vs Veracyte, Inc.
Breaking Down SG&A Expenses: Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.
Alkermes plc or Amneal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Ultragenyx Pharmaceutical Inc.
Cost Management Insights: SG&A Expenses for Amneal Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.